- $10.91m
- $8.79m
- $2.72m
- 25
- 13
- 52
- 20
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.25 | ||
| Price to Tang. Book | 5.01 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.01 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -110.21% | ||
| Return on Equity | -294.13% | ||
| Operating Margin | -124.48% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 2.5 | 3.79 | 3.77 | 2.72 | n/a | n/a | 2.79% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kindly MD, Inc. is a patient-first healthcare and healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. Its specialty outpatient clinical services are reimbursed by Medicare, Medicaid, and commercial insurance contracts as well as offered on a fee-for-service basis. The Company offers both in-person and telemedicine options for patients. It provides management of, but not limited to, pain, functional medicine, cognitive behavioral therapy, addiction, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. The Company also offers traditional therapy sessions with licensed therapists trained in trauma-based therapy and other modalities as described at kindlymd.com. Its services include mental health, medical cards, medication management, sleep support, pain treatment, and weight loss.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 12th, 2019
- Public Since
- May 31st, 2024
- No. of Employees
- 23
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 6,029,648
- Address
- 5097 South 900 East, Suite 100, SALT LAKE CITY, 84117
- Web
- https://kindlymd.com/
- Phone
- +1 3853888220
- Auditors
- Sadler, Gibb & Associates, LLC
Upcoming Events for KDLY
Similar to KDLY
ADVANCED BIOMED
NASDAQ Capital Market
IMEI Technology Health
NASDAQ Capital Market
Akanda
NASDAQ Capital Market
Astrana Health
NASDAQ Capital Market
Basel Medical
NASDAQ Capital Market
FAQ
As of Today at 21:34 UTC, shares in Kindly MD are trading at $1.81. This share price information is delayed by 15 minutes.
Shares in Kindly MD last closed at $1.81 and the price had moved by over the past 365 days. In terms of relative price strength the Kindly MD share price has matched the S&P500 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreKindly MD does not currently pay a dividend.
Kindly MD does not currently pay a dividend.
Kindly MD does not currently pay a dividend.
To buy shares in Kindly MD you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.81, shares in Kindly MD had a market capitalisation of $10.91m.
Here are the trading details for Kindly MD:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: KDLY
Based on an overall assessment of its quality, value and momentum Kindly MD is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kindly MD. Over the past six months, its share price has outperformed the S&P500 Index by +87.03%.
As of the last closing price of $1.81, shares in Kindly MD were trading +19.93% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Kindly MD PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.81.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Kindly MD's directors